Expression of angiogenic growth factors in paragangliomas

Laryngoscope

Volumn 110, Issue 1, 2000, Pages 161-167

  Jyung, Robert W ^a   LeClair, Elizabeth E ^b   Bernat, Richard A ^a   Kang, Thomas S ^a   Ung, Feodor ^c   McKenna, Michael J ^c   Tuan, Rocky S ^b  

^a TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b THOMAS JEFFERSON UNIVERSITY   (United States)

^c MASSACHUSETTS EYE AND EAR INFIRMARY   (United States)

Author keywords

Endothelial cell growth factor; Hypoxia; Platelet derived; Tumor vasculature; Vascular endothelial growth factor

Indexed keywords

PLATELET DERIVED ENDOTHELIAL CELL GROWTH FACTOR; VASCULOTROPIN;

ANGIOGENESIS; ARTICLE; CAROTID BODY TUMOR; CLINICAL ARTICLE; ENDOTHELIUM CELL; ENZYME LINKED IMMUNOSORBENT ASSAY; GLOMUS TUMOR; HUMAN; HUMAN TISSUE; HYPOXIA; IMMUNOHISTOCHEMISTRY; PARAGANGLIOMA; PRIORITY JOURNAL;

EID: 0033967276     PISSN: 0023852X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005537-200001000-00029     Document Type: Article

References (55)

1. Olsen WL, Dillon WP, Kelly WM, Norman D, Brant-Zawadzki M, Newton TH. MR imaging of paragangliomas. AJR Am J Roentgenol 1987;148:201-204.
2. Folkman J. Tumor angiogenesis: therapeutic implications. N Engl J Med 1971;285:1182-1186.
3. Plate KH, Breier G, Welch HA, Risau W. Vascular endothelial growth factor is a potential tumour angiogenesis factor in human gliomas in vivo. Nature 1992;359:845-848.
4. Brown LF, Berse B, Jackman RW, et al. Increased expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in kidney and bladder carcinomas. Am J Pathol 1993;143:1255-1262.
5. Brown LF, Berse B, Jackman RW, et al. Expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in adenocarcinomas of the gastrointestinal tract. Cancer Res 1993;53:4727-4735.
6. Brown LF, Berse B, Jackman RW, et al. Expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in breast cancer. Hum Pathol 1995;26:86-91.
7. Cornali E, Zietz C, Benelli R, et al. Vascular endothelial growth factor regulates angiogenesis and vascular permeability in Kaposi's sarcoma. Am J Pathol 1996;149:1851-1869.
8. Jakeman LB, Armanini M, Phillips HS, Ferrara N. Developmental expression of binding sites and messenger ribonucleic acid for vascular endothelial growth factor suggests a role for this protein in vasculogenesis and angiogenesis. Endocrinology 1993;133:848-859.
9. Senger DR, Galli SJ, Dvorak AM, Perruzzi CA, Harvey VS, Dvorak HF. Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid. Science 1983; 219:983-985.
10. Koch AE, Harlow LA, Haines GK, et al. Vascular endothelial growth factor: a cytokine modulating endothelial function in rheumatoid arthritis. J Immunol 1994;152:4149-4156.
11. Aiello LP, Avery RL, Arrigg PG, et al. Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders. N Engl J Med 1994; 331:1480-1487.
12. Shibuya M, Yamaguchi S, Yamane A, et al. Nucleotide sequence and expression of a novel human receptor-type tyrosine kinase gene (flt) closely related to the fms family. Oncogene 1990;5:519-524.
13. Matthews W, Jordan CT, Gavin M, Jenkins NA, Copeland NG, Lemischka IR. A receptor tyrosine kinase cDNA isolated from a population of enriched primitive hematopoietic cells and exhibiting close genetic linkage to c-kit. Proc Natl Acad Sci USA 1991;88:9026-9030.
14. de Vries C, Escobedo JA, Ueno H, Houck H, Ferrara N, Williams LT. The fms-like tyrosine kinase, a receptor for vascular endothelial growth factor. Science 1992;255:989-991.
15. Hanahan, D. Signaling vascular morphogenesis and maintenance. Science 1997;277:48-50.
16. Giatromanolaki A, Koukourakis MI, Comley M, et al. Platelet-derived endothelial cell growth factor (thymidine phosphorylase) expression in lung cancer. J Pathol 1997;181:196-199.
17. Fox SB, Westwood M, Moghaddam A, et al. The angiogenic factor platelet-derived endothelial cell growth factor/thymidine phosphorylase is up-regulated in breast carcinoma epithelium and endothelium. Br J Cancer 1996;73:275-280.
18. Schwartz EL, Wan E, Wang F-S, Baptiste N. Regulation of expression of thymidine phosphorylase/platelet-derived endothelial cell growth factor in human colon carcinoma cells. Cancer Res 1998;58:1551-1557.
19. Takebayashi Y, Miyadera K, Akiyama S-I, et al. Expression of thymidine phosphorylase in human gastric carcinoma. Jpn J Cancer Res 1996;87:288-295.
20. O'Brien TS, Fox SB, Dickinson AJ, et al. Expression of the angiogenic factor thymidine phosphorylase/platelet-derived endothelial cell growth factor in primary bladder cancers. Cancer Res 1996;56a:4799-4804.
21. Ishikawa F, Miyazono K, Hellman U, et al. Identification of angiogenic activity and the cloning and expression of platelet-derived endothelial cell growth factor. Nature 1989;338:557-562.
22. Haraguchi M, Miyadera K, Uemura K, et al. Angiogenic activity of enzymes. Nature 1994;368:198.
23. Chen J Dinger B, Jyung R, Stensaas L, Fidone S. Upregulation of vascular endothelial growth factor (VEGF) and VEGF receptor (Flk-1) in chronically hypoxic rat carotid body. Abstract presented at the national meeting of the Society for Neuroscience, New Orleans, Louisiana, October 25-30, 1997.
24. Adams JC. Biotin amplification of biotin and horseradish peroxidase signals in histochemical stains. J Histochem Cytochem 1992;40:1457-1463.
25. Sato K, Yamazaki K, Shizume K, et al. Stimulation by thyroid-stimulating hormone and Grave's immunoglobulin G of vascular endothelial growth factor mRNA expression in human thyroid follicles in vitro and fit mRNA expression in the rat thyroid in vivo. J Clin Invest 1995;96:1295-1302.
26. Soh EY, Sobhi SA, Wong MG, et al. Thyroid-stimulating hormone promotes the secretion of vascular endothelial growth factor in thyroid cancer cell lines. Surgery 1996;120:944-947.
27. Balli R, Dallari S, Bergamini G, Maiorana A. Avascular tympanojugular paraganglioma. Laryngoscope 1996;106:721-723.
28. Shibuya M. Role of VEGF-Flt receptor system in normal and tumor angiogenesis. Adv Cancer Res 1995;67:281-316.
29. Spector GJ, Compagno J, Perez CA, et al. Glomus jugulare tumors: effects of radiotherapy. Cancer 1975;35:1316-1321.
30. Leek RD, Harris AL, Lewis CE. Cytokine networks in solid human tumors: regulation of angiogenesis. J Leukoc Biol 1994;56:423-435.
31. Toi M, Inada K, Hoshida S, Suzuki H, Kondo S, Tominaga T. Vascular endothelial growth factor and platelet-derived endothelial cell growth factor are frequently coexpressed in highly vascularized human breast cancer. Clin Cancer Res 1995;1:961-964.
32. Jackson MR, Carney EW, Lye SJ, Ritehie JWK Localization of two angiogenic growth factors (PD-ECGF and VEGF) in human placentae throughout gestation. Placenta 1994;15: 341-353.
33. Relf M, LeJeune S, Scott PAE, et al. Expression of the angiogenic factors vascular endothelial cell growth factor, acidic and basic fibroblast growth factor, transforming growth factor β1, platelet-derived endothelial cell growth factor, placenta growth factor, and pleiotrophin in human primary breast cancer and its relation to angiogenesis. Cancer Res 1997:963-969.
34. Fukuiwa T, Takebayashi Y, Akiba S, et al. Expression of thymidine phosphorylase and vascular endothelial cell growth factor in human head and neck squamous cell carcinoma and their different characteristics. Cancer 1999;85:960-969.
35. Theurillat J-P, Hainfellner J, Maddalena A, Weissenberger J, Aguzzi A. Early induction of angiogenic signals in gliomas of GFAP-v-src transgenic mice. Am J Pathol 1999;154:581-590.
36. Waltenberger J, Claesson-Welsh L, Siegbahn A, Shibuya M, Heldin C-H. Different signal transduction properties of KDR and Flt1, two receptors for vascular endothelial growth factor. J Biol Chem 1994;269(43):26988-26995.
37. Shalaby F, Rossant J, Yamaguchi TP, et al. Failure of blood-island formation and vasculogenesis in Flk-1-deficient mice. Nature 1995;376:62-66.
38. Fox SB, Moghaddam A, Westwood M, et al. Platelet-derived endothelial cell growth factor/thymidine phosphorylase expression in normal tissues: an immunohistochemical study. J Pathol 1995;176:183-190.
39. Heutink P, van der Mey AGL, Sandkuijl LA, et al. A gene subject to genomic imprinting and responsible for hereditary paragangliomas maps to chromosome 11q23-qter. Hum Mol Genet 1992;1:7-10.
40. Iliopoulos O, Levy AP, Jiang C, Kaelin WG, Jr., Goldberg MA. Negative regulation of hypoxia-inducible genes by the von Hippel-Lindau protein. Proc Natl Acad Sci U S A 1996;93: 10595-10599.
41. Wizigmann-Voos S, Breier G, Risau W, Plate KH. Up-regulation of vascular endothelial growth factor and its receptors in von Hippel-Lindau disease-associated and sporadic hemangioblastomas. Cancer Res 1995;55:1358-1364.
42. Hayes HM Jr. An hypothesis for the aetiology of canine chemoreceptor system neoplasms, based upon an epidemiological study of 73 cases among hospital patients. J Small Anim Pract 1975;16:337-343.
43. Arias-Stella J, Bustos F. Chronic hypoxia and chemodectomas in bovines at high altitudes. Arch Pathol Lab Med 1976;100:636-639.
44. Arias-Stella J. Human carotid body at high altitudes. Am J Pathol 1969;55:82a-83a.
45. Edwards C, Heath D. The carotid body in emphysema and left ventricular hypertrophy. J Pathol 1971;104:1-13.
46. Lack EE. Carotid body hypertrophy in patients with cystic fibrosis and cyanotic congenital heart disease. Hum Pathol 1976;8:39-47.
47. Saldana MJ, Salem LE, Travezan R. High altitude hypoxia and chemodectomas. Hum Pathol 1973;4:251-263.
48. Chedid A, Jao W. Hereditary tumors of the carotid bodies and chronic obstructive pulmonary disease. Cancer 1974;33: 1635-1641.
49. Mukhopadhyay D, Tsiokas L, Zhou X-M, Foster D, Brugge JS, Sukhatme VP. Hypoxic induction of human vascular endothelial growth factor expression through c-Src activation. Nature 1995;375:577-581.
50. Griffiths L, Dachs GU, Bicknell R, Harris AL, Stratford IJ. The influence of oxygen tension and pH on the expression of platelet-derived endothelial cell growth factor/thymidine phosphorylase in human breast tumor cells grown in vitro and in vivo. Cancer Res 1997;57:570-572.
51. Parry DM, Li FP, Strong LC, et al;. Carotid body tumors in humans: genetics and epidemiology. J Nat Cancer Inst 1982;68:573-578.
52. Shweiki D, Itin A, Soffer D, Keshet E. Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis. Nature 1992;359:843-845.
53. Shweiki D, Itin A, Neufeld G, Gitay-Goren H, Keshet E. Patterns of expression of vascular endothelial growth factor (VEGF) and VEGF receptors in mice suggest a role in hormonally regulated angiogenesis. J Clin Invest 1993;91: 2235-2243.
54. Osuga Y, Toyoshima H, Mitsuhashi N, Teketani Y. The presence of platelet-derived endothelial cell growth factor in human endometrium and its characteristic expression during the menstrual cycle and early gestational period. Hum Reprod 1995;10:989-993.
55. Wang DG, Barros D'Sa AAB, Johnston CF, Buchanan KD. Oncogene expression in carotid body tumors. Cancer 1996; 77:2581-2587.